Risk of a biased assessment of the evidence when limiting literature searches to the English language: Macrolides in asthma as an illustrative example

Pulmonary Pharmacology and Therapeutics

Volumn 31, Issue , 2015, Pages 109-110

  Brusselle, Guy G ^a,b   Blasi, Francesco ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Asthma; Chinese; English; Macrolides; Meta analysis; Systematic review

Indexed keywords

MACROLIDE;

ANTIBIOTIC THERAPY; ASTHMA; DRUG EFFICACY; DRUG SAFETY; GENETIC SUSCEPTIBILITY; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; ETHNIC GROUP; LANGUAGE; META ANALYSIS (TOPIC); PUBLICATION; STATISTICAL BIAS;

ASTHMA; BIAS (EPIDEMIOLOGY); ETHNIC GROUPS; HUMANS; LANGUAGE; MACROLIDES; META-ANALYSIS AS TOPIC; PERIODICALS AS TOPIC;

EID: 84926297379     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2014.09.006     Document Type: Letter

References (11)

1. Brusselle G.G., Joos G. Is there a role for macrolides in severe asthma?. Curr Opin Pulm Med 2014, 20(1):95-102.
2. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012, 18(5):716-725.
3. Black P.N., Blasi F., Jenkins C.R., et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001, 164(4):536-541.
4. Kraft M., Cassell G.H., Pak J., et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002, 121(6):1782-1788.
5. Richeldi L., Ferrara G., Fabbri L.M., et al. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005, 4. CD002997.
6. Reiter J., Demirel N., Mendy A., et al. Macrolides for the long-term management of asthma-a meta-analysis of randomized clinical trials. Allergy 2013, 68(8):1040-1049.
7. Tong X., Guo T., Liu S., et al. Macrolide antibiotics for treatment of asthma in adults: a meta-analysis of 18 randomized controlled clinical studies. Pulm Pharmacol Ther 2014.
8. Cameron E.J., Chaudhuri R., Mair F., et al. Randomised controlled trial of azithromycin in smokers with asthma. Eur Respir J 2013, 42(5):1412-1415.
9. Woodcock J., Lesko L.J. Pharmacogenetics-tailoring treatment for the outliers. N Engl J Med 2009, 360(8):811-813.
10. Nakamura Y. Pharmacogenomics and drug toxicity. N Engl J Med 2008, 359(8):856-858.
11. Shurin S.B., Nabel E.G. Pharmacogenomics-ready for prime time?. N Engl J Med 2008, 358(10):1061-1063.